This is a non-core endpoint: only basic statistics are computed.
Mesothelioma
C3_MESOTHELIOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
349 |
4. Check minimum number of eventsNone |
349 |
5. Include endpointsNone |
349 |
6. Filter based on genotype QC (FinnGen only) |
339 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C45-C49
- Name in latin
- Mesothelioma
Similar endpoints
↥List of similar endpoints to
Mesothelioma
based on the number of shared cases.
Similar with more cases:
- Mesothelioma, including Hilmo
- Malignant neoplasm of mesothelium and soft tissue
- Solid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 339 | 65 | 274 |
| Unadjusted period prevalence (%) | 0.11 | 0.02 | 0.13 |
| Median age at first event (years) | 72.65 | 70.95 | 73.06 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 349
- Matched controls
- 3490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
289.9
307.7
188
14
C45.0
ICD-10 Finland
Mesothelioma of pleura
+∞
307.7
302
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
124.6
307.7
228
52
130
Kela drug reimbursment
Malignant tumour
+∞
276.1
227
*
A03FA01
ATC
metoclopramide; systemic, rectal
28.5
231.2
208
172
Z51.5
ICD-10 Finland
Palliative care
41.1
226.6
153
65
A04AA01
ATC
ondansetron; systemic, rectal
71.0
205.1
115
24
N02AA05
ATC
oxycodone; systemic
18.5
177.0
229
326
J94.8
ICD-10 Finland
Other specified pleural conditions
52.8
166.5
99
26
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
+∞
160.1
141
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
50.6
160.0
96
26
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
26.6
147.4
112
61
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
+∞
121.1
109
*
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
1491.5
114.3
105
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
28.8
108.9
77
34
JN4BD
NOMESCO Finland
Extensive body CT
15.4
104.7
105
95
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
48.5
95.8
57
14
WX302
NOMESCO Finland
Thoracal epidural anesthesy
28.8
88.9
62
26
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
77.0
71
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
12.8
70.2
75
73
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.8
61.8
105
183
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
18.7
60.2
50
31
TGA30
NOMESCO Finland
Thoracocentesis
88.3
59.5
65
9
A04AA02
ATC
granisetron; systemic, transdermal
+∞
54.6
51
*
GAC00
NOMESCO Finland
Biopsy of pleura
166.1
54.6
56
*
L01CA04
ATC
vinorelbine; systemic
+∞
53.5
50
*
GD1AD
NOMESCO Finland
Thorax CT examination
9.6
52.2
68
86
UGC12
NOMESCO Finland
Flexible bronchoscopy
7.4
49.9
84
143
JN4AD
NOMESCO Finland
Body CT examination
8.4
48.6
71
103
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
184.8
47.1
48
*
C45.9
ICD-10 Finland
Mesothelioma, unspecified
+∞
43.7
41
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
472.2
43.2
42
*
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
+∞
42.6
40
*
1BA04, ,
NOMESCO Finland
+∞
40.4
38
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
40.4
38
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
39.3
37
*
ZX120
NOMESCO Finland
Intravenous
7.1
39.2
66
111
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
+∞
38.2
36
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
37.1
35
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
90.2
36.7
40
5
J94.9
ICD-10 Finland
Pleural condition, unspecified
62.4
34.0
39
7
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
33.9
32
*
B03BA03
ATC
hydroxocobalamin; parenteral
5.6
32.0
69
147
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
+∞
30.7
29
*
A06AH03
ATC
naloxegol; oral
90.9
30.3
33
*
J01MA14
ATC
moxifloxacin; systemic
5.1
29.7
71
165
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
7.6
29.6
45
67
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
113.1
29.2
31
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.6
28.7
234
1259
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
28.5
27
*
WZC30
NOMESCO Finland
Teaching
4.5
27.7
80
216
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.2
27.1
43
67
XX3DW
NOMESCO Finland
Time consuming IT work
7.5
26.9
41
61
R84
ICPC
Malignant neoplasm bronchus/lung
280.2
26.1
26
*
WX600
NOMESCO Finland
Single shot through catheter
145.8
26.0
27
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.5
25.9
126
488
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
25.9
122
463
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.2
25.7
83
243
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
+∞
25.3
24
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
25.3
24
*
L03AA13
ATC
pegfilgrastim; parenteral
256.9
24.0
24
*
TK800
NOMESCO Finland
Hemodialysis
9.5
23.6
29
33
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
245.4
22.9
23
*
N02AA01
ATC
morphine; systemic, rectal
20.1
22.2
33
18
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
85.8
22.0
24
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
234.1
21.9
22
*
J01MA12
ATC
levofloxacin; systemic
3.2
20.8
109
434
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.2
20.5
45
96
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
18.9
18
*
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
18.9
18
*
A79
ICPC
Malignancy NOS
+∞
18.9
18
*
GAA31
NOMESCO Finland
Thoracoscopy
200.3
18.7
19
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
200.3
18.7
19
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
22.3
17.6
25
12
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
17.1
17.3
27
17
116
Kela drug reimbursment
Prostate cancer
+∞
16.8
16
*
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
178.2
16.6
17
*
A04AD12
ATC
aprepitant; systemic
+∞
15.7
15
*
GDD20
NOMESCO Finland
Extended pneumonectomy
+∞
15.7
15
*
R85
ICPC
Malignant neopl respiratory other
+∞
15.7
15
*
L03AA02
ATC
filgrastim; parenteral
167.2
15.6
16
*
R82
ICPC
Pleurisy/pleural effusion
167.2
15.6
16
*
B01AB10
ATC
tinzaparin; parenteral
4.1
15.0
44
118
C45
ICD-10 Finland
Mesothelioma
+∞
14.7
14
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
14.5
148
807
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.8
14.4
47
136
N03AX16
ATC
[U] pregabalin
2.7
14.3
96
428
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
55.7
13.9
16
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
13.8
102
476
GAC30
NOMESCO Finland
Artificial pneumothorax
+∞
13.6
13
*
WW200, ,
SPAT
0.1
13.6
8
519
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
12.6
12
*
C45.7
ICD-10 Finland
Mesothelioma of other sites
+∞
12.6
12
*
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
+∞
12.6
12
*
GAC43
NOMESCO Finland
Total decortication of pleura
134.6
12.5
13
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.3
12.5
22
19
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
12.1
98
474
H02AB06
ATC
prednisolone; systemic
2.2
12.1
186
1182
SPAT1109
SPAT
Analgesia with portable analgesic pump
48.4
12.0
14
*
Z2446
NOMESCO Finland
Social worker
4.0
11.7
35
95
9050/3-C48.2
ICD-O-3
Mesothelioma, malignant of peritoneum, NOS
+∞
11.5
11
*
GDD96
NOMESCO Finland
Other pneumonectomy
+∞
11.5
11
*
L02AE02
ATC
leuprorelin; implant, parenteral
123.9
11.5
12
*
R18
ICD-10 Finland
Ascites
9.6
10.7
21
23
R4110
NOMESCO Finland
Physiotherapy
2.3
10.6
106
559
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
10.6
55
212
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
R06.0
ICD-10 Finland
Dyspnoea
2.2
10.5
129
741
WW500
NOMESCO Finland
Blood transfusion
7.9
10.4
23
31
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.5
10.2
20
38
ZX090
NOMESCO Finland
Other technic of radiotherapy
41.3
10.0
12
*
J86.9
ICD-10 Finland
Pyothorax without fistula
11.1
9.9
18
17
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
56.6
9.7
11
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.5
9.6
19
21
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
102.7
9.5
10
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
31.0
9.5
12
*
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
+∞
9.4
9
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
9.4
143
882
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.7
9.2
19
23
WF002
NOMESCO Finland
Radical radiotherapy
37.7
9.1
11
*
Z2221
NOMESCO Finland
Medical doctor
2.2
9.0
97
524
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
24.8
9.0
12
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.4
8.8
33
105
J93.9
ICD-10 Finland
Pneumothorax, unspecified
28.3
8.5
11
*
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
28.3
8.5
11
*
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
7.0
8.5
20
30
Y77
ICPC
Malignant neoplasm prostate
92.2
8.4
9
*
GAC46
NOMESCO Finland
Partial decortication of pleura
92.2
8.4
9
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
92.2
8.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
8.4
8
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
8.4
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.4
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
9052/3-C48.2
ICD-O-3
Epithelioid mesothelioma, malignant of peritoneum, NOS
+∞
8.4
8
*
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.0
8.3
*
230
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
34.2
8.1
10
*
N06DX01
ATC
memantine; oral
0.1
8.1
*
278
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.1
8.0
17
22
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.8
127
792
D70.82
ICD-10 Finland
Drug-induced neutropenia
46.0
7.7
9
*
B01AB04
ATC
dalteparin; parenteral
4.0
7.6
22
58
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
7.3
7
*
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
6.3
7.2
18
30
B01AB05
ATC
enoxaparin; parenteral
1.9
7.0
111
683
J93.8
ICD-10 Finland
Other pneumothorax
14.1
6.9
11
8
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
6.9
80
440
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
8.5
6.9
14
17
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.6
6.8
13
14
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
17.1
6.8
10
6
JAL30
NOMESCO Finland
Omentectomy
23.0
6.7
9
*
C10AA05
ATC
atorvastatin; oral
0.5
6.7
87
1369
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
6.7
56
271
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
71.1
6.4
7
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
71.1
6.4
7
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
71.1
6.4
7
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
6.4
55
268
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.4
70
1168
N05CF01
ATC
zopiclone; oral
1.8
6.3
121
787
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
6.3
6
*
GAC20
NOMESCO Finland
Excision or destruction of lesion of pleura
+∞
6.3
6
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
XX1XW
NOMESCO Finland
Extensive written report from radiologist
5.5
6.2
17
32
C10AX09
ATC
ezetimibe; oral
0.3
6.2
13
453
WW200
NOMESCO Finland
Immunization
5.4
6.1
17
33
R96
ICPC
Asthma
0.1
6.1
*
178
ZXE00
NOMESCO Finland
One hour or less
1.8
6.1
128
854
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
140
39
59.27
235.41
2.1
1.3
1693.77
2509.39
e6/l
0.54
115
28
137
35
63.79
235.23
2.1
1.4
39910.31
212878.39
e6/l
0.55
100
23
106
60
24.94
136.72
2.2
1.4
—
—
—
0
0
124
101
18.49
133.21
2.4
3.6
—
—
—
0
0
117
129
13.14
102.56
2.2
1.3
2.05
2.90
ug/l
3.30
93
95
134
294
6.78
63.15
3.0
2.3
203.40
241.50
u/l
8.85
134
272
68
71
11.65
60.35
1.5
1.4
—
—
—
0
0
145
361
6.16
59.34
5.4
2.6
0.78
0.83
mmol/l
6.20
138
330
230
1310
3.22
23.93
17.3
5.5
5.10
4.65
e9/l
0.93
206
1130
29
34
9.21
23.09
7.9
5.6
10.87
12.44
mg/l
1.03
29
34
34
55
6.74
20.59
1.2
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
95
4.76
16.89
3.0
2.5
0.28
0.36
u/ml
0.70
21
49
198
1182
2.56
16.46
8.2
5.3
1.20
1.20
mmol/l
0.26
189
1040
190
1119
2.53
16.16
7.8
3.6
29.94
34.92
g/l
17.88
183
1031
209
1292
2.54
15.94
9.7
5.8
1.20
1.20
mmol/l
0.05
187
1102
151
823
2.47
14.88
6.7
2.1
2.35
2.34
mmol/l
0.01
135
665
119
585
2.57
14.58
3.5
2.1
—
—
—
0
0
107
506
2.61
14.15
6.3
2.2
2.53
2.44
mmol/l
11.28
96
420
170
2407
0.43
13.60
5.3
7.2
41.62
41.49
mmol/mol
0.06
146
2185
217
1431
2.37
13.41
9.5
21.1
1.14
1.43
inr
6.29
36
388
25
29
9.20
12.23
1.9
1.7
101.60
17.11
u/ml
0.73
25
29
178
2435
0.45
11.94
3.6
5.0
1.38
1.37
mmol/l
0.17
146
2181
182
2464
0.45
11.72
3.5
5.0
4.31
4.25
mmol/l
0.35
148
2228
190
2531
0.45
11.67
3.6
5.7
2.52
2.46
mmol/l
0.41
152
2275
22
30
7.75
9.86
1.1
1.1
—
—
—
0
0
40
138
3.14
9.32
5.3
4.4
25.91
24.80
mmol/l
1.25
40
129
13
7
19.22
9.00
1.6
1.6
—
—
—
0
0
179
2350
0.51
8.62
3.2
4.5
1.22
1.27
mmol/l
0.44
141
2083
89
474
2.18
8.50
2.0
1.8
—
—
—
0
0
115
703
1.95
7.43
4.5
2.4
30.38
35.93
u/l
1.33
109
667
89
507
2.01
6.98
1.7
1.6
1.94
1.63
mg/l
0.44
70
405
121
775
1.86
6.66
3.8
2.1
55.54
62.52
u/l
0.51
114
710
160
1124
1.78
6.45
3.8
2.4
—
—
—
0
0
116
746
1.83
6.23
2.5
2.8
0.92
0.43
e6/l
0.87
93
557
40
172
2.50
6.18
1.6
1.5
—
—
—
0
0
206
2508
0.56
6.16
4.8
5.2
6.31
6.18
mmol/l
0.44
176
2227
61
1043
0.50
5.84
3.5
3.9
2.98
9.97
mg/mmol
4.56
32
677
17
35
5.05
5.82
1.4
1.3
—
—
—
0
0
18
51
3.67
5.68
1.4
1.3
—
—
—
0
0
184
2286
0.59
5.57
5.4
4.1
2.26
2.03
mu/l
0.58
165
2018
64
350
2.01
5.54
9.0
6.3
1.68
1.13
mmol/l
0.77
57
274
239
1935
1.75
5.44
16.2
5.0
88.37
76.84
u/l
4.11
234
1759
18
53
3.53
5.38
1.4
1.3
—
—
—
0
0
65
362
1.98
5.34
10.1
5.9
103.35
104.69
mmol/l
1.38
65
362
205
1609
1.66
5.07
8.2
4.4
6.82
6.96
mmol/l
0.54
199
1506
140
1000
1.67
4.98
2.6
3.0
—
—
—
0
0
13
24
5.58
4.96
1.4
1.3
—
—
—
0
0
39
186
2.23
4.79
2.0
1.6
—
—
—
0
0
14
31
4.66
4.61
2.4
4.2
—
—
—
0
0
58
334
1.88
4.30
1.8
1.7
—
—
—
0
0
36
174
2.19
4.29
1.8
1.5
—
—
—
0
0
13
29
4.61
4.29
1.5
1.2
—
—
—
0
0
12
25
4.93
4.22
1.5
1.4
—
—
—
0
0
61
361
1.84
4.15
5.3
5.4
1.03
1.02
mmol/l
0.10
56
327
57
332
1.86
4.08
1.8
1.8
—
—
—
0
0
10
19
5.38
3.85
1.6
1.2
—
—
—
0
0
8
12
6.79
3.69
1.4
1.5
109.50
55.87
pmol/l
—
8
12
91
1260
0.62
3.64
1.7
2.1
92.52
91.34
pmol/l
0.08
53
667
16
57
2.89
3.57
2.1
1.9
14.69
15.89
%
—
8
31
11
27
4.17
3.42
1.5
1.3
—
—
—
0
0
26
121
2.24
3.42
2.3
1.6
—
—
—
0
0
17
65
2.70
3.35
1.5
1.5
0.02
0.12
iu/ml
—
7
17
13
43
3.10
3.28
1.5
1.2
—
—
—
0
0
66
953
0.62
3.05
1.9
2.1
75.96
77.19
nmol/l
0.11
54
805
9
22
4.17
2.90
1.0
1.4
—
—
—
0
0
6
9
6.76
2.88
1.7
1.2
—
—
—
0
0
6
9
6.76
2.88
1.7
1.2
—
—
—
0
0
136
1679
0.69
2.87
4.5
4.2
2.50
2.10
ug/l
0.73
113
1484
11
33
3.41
2.83
1.5
1.2
—
—
—
0
0
16
65
2.53
2.83
1.6
1.2
—
—
—
0
0
16
65
2.53
2.83
1.6
1.2
—
—
—
0
0
23
111
2.15
2.80
2.3
1.5
—
—
—
0
0
65
438
1.59
2.75
2.4
2.8
1.66
1.13
e6/l
0.35
35
245
7
14
5.08
2.74
1.7
1.1
—
—
—
0
0
84
601
1.52
2.73
5.3
3.9
76.67
402.75
ng/l
2.72
72
518
93
1223
0.67
2.70
3.1
3.7
0.00
0.00
estimate
-0.00
27
194
46
702
0.60
2.64
1.6
1.8
518.82
406.18
pmol/l
1.34
38
566
148
1780
0.71
2.58
4.8
3.2
14.99
15.02
pmol/l
0.05
134
1560
106
1348
0.69
2.53
3.6
4.1
22.03
24.60
%
1.09
55
675
93
1204
0.69
2.42
4.3
5.0
0.00
0.00
estimate
-0.00
27
200
16
72
2.28
2.31
1.1
1.3
—
—
—
0
0
94
1206
0.70
2.30
3.1
3.7
0.00
0.00
estimate
0.50
26
221
10
34
3.00
2.30
1.6
1.2
—
—
—
0
0
56
381
1.56
2.28
2.0
2.4
17.22
23.63
%
2.97
51
322
70
938
0.68
2.15
3.2
4.0
—
—
—
0
0
5
10
5.05
2.07
1.6
5.9
—
—
—
0
0
8
26
3.12
2.02
1.1
1.3
—
—
—
0
0
15
71
2.16
1.95
1.8
1.8
120.78
131.02
g/l
—
9
52
252
2732
0.72
1.95
50.5
21.4
122.53
136.10
g/l
27.40
244
2665
252
2732
0.72
1.95
51.0
21.5
37.74
39.89
%
7.47
231
2474
252
2732
0.72
1.95
50.2
21.3
4.25
4.47
e12/l
8.94
239
2618
244
2658
0.73
1.94
40.8
17.3
83.69
88.70
umol/l
1.23
244
2658
252
2731
0.72
1.93
50.2
21.3
304.93
230.69
e9/l
24.64
239
2641
7
22
3.22
1.89
1.1
1.4
—
—
—
0
0
249
2688
0.74
1.69
37.7
18.4
4.04
4.03
mmol/l
0.22
240
2602
24
144
1.72
1.62
2.8
3.9
24.82
24.12
mmol/l
0.33
24
139
249
2683
0.75
1.61
37.7
18.3
138.11
139.78
mmol/l
12.18
241
2596
62
463
1.41
1.61
2.3
2.7
2.07
0.97
e6/l
0.81
32
269
10
44
2.31
1.57
1.4
1.4
—
—
—
0
0
245
2640
0.76
1.53
19.9
9.2
23.47
25.03
u/l
0.98
237
2500
9
37
2.47
1.49
4.4
2.2
62.78
60.57
%
—
9
37
6
22
2.76
1.44
1.3
1.3
—
—
—
0
0
10
198
0.49
1.43
8.6
2.1
73.80
58.33
ml/min/173m2
—
5
73
6
23
2.64
1.37
1.3
1.3
—
—
—
0
0
6
23
2.64
1.37
1.5
1.3
—
—
—
0
0
6
23
2.64
1.37
1.5
1.3
—
—
—
0
0
6
23
2.64
1.37
1.3
1.3
—
—
—
0
0
6
23
2.64
1.37
1.5
1.3
—
—
—
0
0
8
34
2.38
1.30
1.1
1.3
—
—
—
0
0
8
34
2.38
1.30
1.1
1.3
—
—
—
0
0
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
5
19
2.65
1.22
1.2
1.2
—
—
—
0
0
48
365
1.37
1.15
1.2
1.2
36.09
44.85
iu/ml
—
8
101
5
22
2.29
1.03
1.0
1.1
—
—
—
0
0
119
1037
1.22
1.00
3.2
3.2
1081.06
1828.99
ng/l
2.64
110
898
45
348
1.34
0.98
1.1
1.3
33.20
15.69
u/ml
—
8
117
5
23
2.19
0.98
1.2
1.4
—
—
—
0
0
5
23
2.19
0.98
1.2
1.4
—
—
—
0
0
0
30
0.00
0.97
0.0
1.0
—
613.50
—
0
20
0
30
0.00
0.97
0.0
1.0
—
48.33
—
0
19
6
27
2.24
0.94
1.2
1.3
—
—
—
0
0
55
673
0.78
0.90
3.1
4.0
0.00
0.00
estimate
-0.00
25
193
8
43
1.88
0.88
1.3
1.3
—
—
—
0
0
29
386
0.73
0.86
7.4
7.4
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
11
71
1.57
0.63
1.0
1.1
—
—
—
0
0
11
71
1.57
0.63
1.0
1.1
—
—
—
0
0
8
51
1.58
0.61
1.1
1.1
—
—
—
0
0
88
985
0.86
0.59
2.4
2.6
537.27
159.44
ug/l
2.81
83
883
5
86
0.58
0.57
1.0
1.7
—
—
—
0
0
38
313
1.24
0.56
3.1
3.5
6.16
5.84
kpa
0.62
38
303
224
2343
0.88
0.54
32.5
13.6
76.24
72.18
ml/min/173m2
2.45
208
1889
65
735
0.86
0.50
2.6
2.7
16291.56
10093.34
umol/l
0.21
54
636
57
651
0.85
0.49
1.6
1.8
1123.19
1151.80
nmol/l
0.08
37
492
12
86
1.41
0.45
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
8
61
1.32
0.40
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.2
5.9
—
191.00
iu/ml
—
0
5
32
370
0.85
0.34
4.3
5.2
33.73
32.12
%
0.29
22
253
18
218
0.82
0.31
1.0
1.2
—
—
—
0
0
7
53
1.33
0.31
1.7
1.8
—
—
—
0
0
33
291
1.15
0.27
4.7
3.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
138.31
—
0
13
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.04
—
0
8
6
53
1.13
0.19
1.0
1.1
—
—
—
0
0
8
72
1.11
0.16
1.3
1.6
—
—
—
0
0
148
1437
1.05
0.16
5.5
3.0
63.75
52.53
u/l
0.64
137
1307
7
86
0.81
0.14
1.0
1.3
—
—
—
0
0
77
738
1.06
0.13
1.9
2.1
3.64
2.95
mg/l
1.32
69
619
24
261
0.91
0.12
3.7
2.9
4.78
4.45
kpa
0.34
24
250
123
1199
1.04
0.11
4.8
4.2
39.21
83.69
ng/l
0.85
108
931
251
2481
1.04
0.10
40.2
14.5
54.83
27.59
mg/l
15.89
238
1957
12
135
0.88
0.10
5.5
4.1
1.77
1.67
%
0.16
12
130
5
46
1.09
0.09
1.6
1.1
—
—
—
0
0
6
55
1.09
0.09
3.3
2.7
105.00
104.35
mmol/l
—
6
55
7
67
1.05
0.08
1.4
1.7
—
—
—
0
0
109
1070
1.03
0.06
2.5
2.2
—
—
—
0
0
21
199
1.06
0.04
2.1
1.8
0.17
0.20
g/l
0.90
21
175
90
913
0.98
0.03
3.0
2.9
0.82
0.78
ug/l
0.20
68
652
186
1873
0.99
0.03
4.2
4.0
29.18
12.94
mm/h
9.22
179
1680
12
116
1.04
0.00
1.1
1.3
—
—
—
0
0
15
154
0.97
0.00
2.7
2.7
1.19
1.11
%
0.22
15
154
0
6
0.00
-0.00
0.0
6.5
—
4.98
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.0
—
—
—
0
0
9
96
0.94
-0.00
1.2
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
15
150
1.00
-0.00
2.7
2.6
0.59
0.64
%
0.21
15
150
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
2305.00
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
1.25
—
0
6
0
8
0.00
-0.00
0.0
3.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
75.40
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
4.2
—
140.00
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
9.16
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MESOTHELIOMA – Mesothelioma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).